On February 26, 2020 Leap Therapeutics, Inc. (Nasdaq: LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, reported that Christopher K. Mirabelli, Ph.D., Chairman, President and Chief Executive Officer, Douglas E. Onsi, Chief Financial Officer, and Cynthia Sirard, MD, Vice President, Clinical Research & Development, will present a corporate overview at the Cowen 40th Annual Health Care Conference, being held in Boston on March 2-4, 2020 (Press release, Leap Therapeutics, FEB 26, 2020, https://www.prnewswire.com/news-releases/leap-therapeutics-to-present-at-cowen-40th-annual-health-care-conference-301011310.html [SID1234554840]). The presentation will be followed by a 30-minute breakout session.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Leap Presentation and Breakout Session Details:

Cowen 40th Annual Health Care Conference
Date: Wednesday, March 4, 2020
Presentation Time: 8:40 a.m. Eastern Time
Breakout Session Time: 9:20 a.m. Eastern Time

The presentation will be webcast live and may be accessed on the Investors page of the company’s website at View Source, where a replay of the event will also be available for a limited time.